These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11161135)

  • 1. Ethnic differences in C-peptide levels and anti-GAD antibodies in South African patients with diabetic ketoacidosis.
    Rheeder P; Stolk RP; Grobbee DE
    QJM; 2001 Jan; 94(1):39-43. PubMed ID: 11161135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.
    Banerji MA; Chaiken RL; Huey H; Tuomi T; Norin AJ; Mackay IR; Rowley MJ; Zimmet PZ; Lebovitz HE
    Diabetes; 1994 Jun; 43(6):741-5. PubMed ID: 8194658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet immunity and beta cell reserve of indigenous Black South Africans with ketoacidosis at initial diagnosis of diabetes.
    Ekpebegh C; Longo-Mbenza B; Blanco-Blanco E
    Ethn Dis; 2013; 23(2):196-201. PubMed ID: 23530301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.
    Panz VR; Kalk WJ; Zouvanis M; Joffe BI
    Diabet Med; 2000 Jul; 17(7):524-7. PubMed ID: 10972582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study.
    Raubenheimer PJ; Skelton J; Peya B; Dave JA; Levitt NS
    Diabetologia; 2024 Mar; 67(3):494-505. PubMed ID: 38240751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
    Umpierrez GE; Clark WS; Steen MT
    Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up.
    Pitteloud N; Philippe J
    Schweiz Med Wochenschr; 2000 Apr; 130(16):576-82. PubMed ID: 10842773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.
    Rattarasarn C; Aguilar Diosdado M; Soonthornpun S
    Diabetes Res Clin Pract; 1997 Sep; 37(3):193-7. PubMed ID: 9306041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in children with type 2 diabetes mellitus.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis.
    Umpierrez GE; Woo W; Hagopian WA; Isaacs SD; Palmer JP; Gaur LK; Nepom GT; Clark WS; Mixon PS; Kitabchi AE
    Diabetes Care; 1999 Sep; 22(9):1517-23. PubMed ID: 10480519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young Chinese adults with new onset of diabetic ketoacidosis--clinical course, autoimmune status and progression of pancreatic beta-cell function.
    Li JK; Chan JC; Zimmet PZ; Rowley MJ; Mackay IR; Cockram CS
    Diabet Med; 2000 Apr; 17(4):295-8. PubMed ID: 10821296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
    Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
    Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
    Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients.
    Ahn CW; Kim HS; Nam JH; Song YD; Lim SK; Kim KR; Lee HC; Huh KB
    Diabet Med; 2002 Mar; 19(3):227-33. PubMed ID: 11918625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes.
    Gu W; Hu J; Wang W; Li L; Tang W; Sun S; Cui W; Ye L; Zhang Y; Hong J; Zhu D; Ning G
    Diabetes Care; 2012 Jul; 35(7):1413-9. PubMed ID: 22723579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of type I and II diabetes in newly diagnosed diabetic patients: Measuring C-Peptide level.
    Shahbazian H; Aleali AM; Rashidi H; Latifi SM; Rashidi M; Yazdanpanah L; Zaman F; Payami SP; Moradi L; Jahanshahi A; Sedaghat A; Zakerkish M; Moradi M
    Diabetes Metab Syndr; 2019; 13(3):1833-1835. PubMed ID: 31235102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.